Category results for "Prescription Drugs"

Access to Dentists and Pharmacists Predicts Higher Rates of Opioid Abuse: Study

People who live in counties with higher concentrations of dentists and pharmacists are at increased risk of abusing prescription opioids, a new study suggests.

Commentary: The Quest for Alternatives to Opioids in Chronic Pain: The Role of The Interventional Pain Physician

In an effort to eliminate or reduce opioid abuse, Dr. Timothy Deer, President and CEO of The Center for Pain Relief, explains various pain treatment options physicians and patients should consider.

Experts Voice Concern Over FDA Approval of New Hydrocodone Drug

The Food and Drug Administration’s approval of the first pure hydrocodone drug concerns law enforcement agencies and addiction experts, who predict overdose deaths will increase, Newsday reports.

Defense Department Health Plan Will Cover Buprenorphine and Methadone

The Defense Department’s healthcare plan will cover the opioid addiction medications buprenorphine and methadone starting next month, according to the Air Force Times.

30% of Veterans Given Psychiatric Drugs Aren’t Diagnosed With Mental Health Problem

A new study finds 30 percent of U.S. veterans prescribed psychiatric medications do not have a diagnosed mental health problem.

Study: 10% of Teens Treated in the ER Admit to Misusing Prescription Drugs

Ten percent of 14- to 20-year-olds treated in the emergency room for any reason say they have misused prescription drugs at least once in the last year, a new study finds.

Doctors Try New Non-Narcotic Approach to Pain Management After Surgery

Doctors are trying a new approach to pain management after surgery, in an attempt to reduce patients’ reliance on narcotic painkillers, according to The Wall Street Journal.

First Single-Ingredient Hydrocodone Drug Receives FDA Approval

The Food and Drug Administration on Friday approved the first pure hydrocodone drug in the United States. The drug, Zohydro ER (extended release), was approved for patients with pain that requires daily, around-the-clock, long-term treatment that cannot be treated with other drugs.

FDA Hydrocodone Recommendation Was Long Opposed by Business, Patient Groups

Business and patient groups waged a costly lobbying campaign against tighter prescribing regulations for hydrocodone products for many years, according to The New York Times. Last week, the Food and Drug Administration recommended tighter restrictions for products containing hydrocodone and other painkillers such as acetaminophen or aspirin.

Commentary: DEA and You – Ending the Epidemic of Prescription Drug Abuse Together

The next National Prescription Take-Back Day is Saturday, October 26 at more than 5,000 locations around the country. Your participation along with that of your friends, neighbors and community leaders will be critical, as it always is, to the success of this campaign that takes tons of drugs out of harm’s way and ensures their safe and secure disposal, says DEA Administrator Michele Leonhart.

Page 9 of 75...8910...20...